Compare SMTI & KRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SMTI | KRMD |
|---|---|---|
| Founded | 1982 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 208.2M | 177.8M |
| IPO Year | 2008 | 2019 |
| Metric | SMTI | KRMD |
|---|---|---|
| Price | $21.83 | $4.10 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | ★ $34.00 | $6.50 |
| AVG Volume (30 Days) | 48.6K | ★ 101.3K |
| Earning Date | 05-12-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 53.85 |
| EPS | ★ 0.05 | N/A |
| Revenue | $15,586,976.00 | ★ $41,127,366.00 |
| Revenue This Year | $17.31 | $20.32 |
| Revenue Next Year | $12.48 | $17.37 |
| P/E Ratio | $435.00 | ★ N/A |
| Revenue Growth | ★ 32.47 | 22.23 |
| 52 Week Low | $16.05 | $2.91 |
| 52 Week High | $35.70 | $6.61 |
| Indicator | SMTI | KRMD |
|---|---|---|
| Relative Strength Index (RSI) | 50.76 | 54.17 |
| Support Level | $20.50 | $4.05 |
| Resistance Level | $24.17 | $4.28 |
| Average True Range (ATR) | 1.46 | 0.16 |
| MACD | -0.15 | 0.00 |
| Stochastic Oscillator | 42.99 | 73.57 |
Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.
KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.